What is Bright Uro?
Founded in 2021 and headquartered in Aliso Viejo, California, Bright Uro operates within the medical device industry. The company is focused on developing innovative solutions, likely targeting unmet needs within its specialized market. Given the substantial enterprise-level funding and recent strategic investment, Bright Uro appears to be in a scaling phase, aiming to expand its product offerings and market reach. The company's commitment to advancing medical technology is evident through its continuous pursuit of capital to fuel its ambitious objectives.
How much funding has Bright Uro raised?
Bright Uro has raised a total of $74.7M across 4 funding rounds:
Angel/Seed
$6M
Series A
$23M
Private Equity
$14.7M
Private Equity
$31M
Angel/Seed (2022): $6M with participation from Academy Investor Network
Series A (2023): $23M led by Laborie
Private Equity (2025): $14.7M, investors not publicly disclosed
Private Equity (2025): $31M, investors not publicly disclosed
Key Investors in Bright Uro
Academy Investor Network
Academy Investor Network is an entity that has participated in the early-stage funding of Bright Uro, indicating a potential focus on emerging companies within the medical device sector.
Laborie
Laborie, a company specializing in pelvic health and gastrointestinal equipment, has made a strategic investment in Bright Uro, suggesting a potential synergy in the medical device market, particularly in areas related to urology and diagnostics.
What's next for Bright Uro?
With the infusion of $14.7M in its latest strategic investment, Bright Uro is poised for significant expansion. This capital injection is expected to accelerate product development, enhance manufacturing capabilities, and broaden market access. The company's strategic focus will likely involve leveraging this funding to solidify its position in the medical device landscape, potentially through further research and development, strategic partnerships, or market acquisitions. The sustained investor interest, as indicated by the total funding of $74.7M, suggests a strong belief in Bright Uro's long-term vision and its capacity to deliver impactful healthcare solutions.
See full Bright Uro company page
